Key result
This review outlines the genetic etiology, pathophysiology, and pharmacogenetics of various cardiomyopathies and heart failure to enhance cardiovascular nursing care.
This review summarizes the genetic basis of various cardiomyopathies and pharmacogenetics to inform and enhance cardiovascular nursing care for heart failure patients.
May inform genetically guided nursing in cardiomyopathies; leaves open prospective validation before practice change.
This paper presents the main causes of heart failure (HF) and an update on the genetics studies on each cause. The review includes a delineation of the etiology and fundamental pathophysiology of HF and provides rational for treatment for the patient and family. Various cardiomyopathies are discussed, including primary cardiomyopathies, mixed cardiomyopathies, cardiomyopathies that involve altered cardiac muscle along with generalized multiorgan disorders, and various cardiovascular conditions, such as coronary artery disease (ischemic cardiomyopathy) and hypertension (hypertensive cardiomyopathy). A brief review of pharmacogenetics and HF is presented. The application of the genetic components of cardiomyopathy and pharmacogenetics is included to enhance cardiovascular nursing care.
No takes yet. Share an insight, caveat, or question.
Frazier et al. (2009) conducted a review in Heart failure. This review outlines the genetic etiology, pathophysiology, and pharmacogenetics of various cardiomyopathies and heart failure to enhance cardiovascular nursing care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: